Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Scaldaferri

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
European Review for Medical and Pharmacological Sciences|February 18, 2012
The use of anti-spasmodics in the treatment of irritable bowel syndrome: focus on otilonium bromideE Forte, M Pizzoferrato, L Lopetuso, et al.
European Review for Medical and Pharmacological Sciences|January 21, 2014
Breath tests sustainability in hospital settings: cost analysis and reimbursement in the Italian National Health SystemM Volpe, F Scaldaferri, V Ojetti, et al.
European Review for Medical and Pharmacological Sciences|January 21, 2014
Editorial--Is there still a place for breath tests in gastroenterology?A Gasbarrini, F Scaldaferri, F Franceschi, et al.
QJM : Monthly Journal of the Association of Physicians|January 11, 2017
Anti-TNFα antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease: an Irish Cohort StudyS Kirthi Jeyarajah, A M Tobin, M Hussey, et al.
European Review for Medical and Pharmacological Sciences|April 10, 2015
The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectorsL R Lopetuso, F Scaldaferri, G Bruno, et al.
European Review for Medical and Pharmacological Sciences|June 18, 2009
New therapeutic approach in inflammatory bowel diseaseA Papa, G Mocci, F Scaldaferri, et al.
European Review for Medical and Pharmacological Sciences|December 2, 2016
The role of diet on gut microbiota compositionS Bibbò, G Ianiro, V Giorgio, et al.
European Review for Medical and Pharmacological Sciences|January 11, 2005
Platelets: new players in the mucosal scenario of inflammatory bowel diseaseS Danese, F Scaldaferri, A Papa, et al.
Drugs of Today (Barcelona, Spain : 1998)|April 12, 2018
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an updateG Holleran, F Scaldaferri, G Ianiro, et al.
European Review for Medical and Pharmacological Sciences|January 21, 2010
Small bowel bacterial overgrowth and type 1 diabetesV Ojetti, D Pitocco, E Scarpellini, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
European Review for Medical and Pharmacological Sciences|February 18, 2012
The use of anti-spasmodics in the treatment of irritable bowel syndrome: focus on otilonium bromideE Forte, M Pizzoferrato, L Lopetuso, et al.
European Review for Medical and Pharmacological Sciences|January 21, 2014
Breath tests sustainability in hospital settings: cost analysis and reimbursement in the Italian National Health SystemM Volpe, F Scaldaferri, V Ojetti, et al.
European Review for Medical and Pharmacological Sciences|January 21, 2014
Editorial--Is there still a place for breath tests in gastroenterology?A Gasbarrini, F Scaldaferri, F Franceschi, et al.
QJM : Monthly Journal of the Association of Physicians|January 11, 2017
Anti-TNFα antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease: an Irish Cohort StudyS Kirthi Jeyarajah, A M Tobin, M Hussey, et al.
European Review for Medical and Pharmacological Sciences|April 10, 2015
The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectorsL R Lopetuso, F Scaldaferri, G Bruno, et al.
European Review for Medical and Pharmacological Sciences|June 18, 2009
New therapeutic approach in inflammatory bowel diseaseA Papa, G Mocci, F Scaldaferri, et al.
European Review for Medical and Pharmacological Sciences|December 2, 2016
The role of diet on gut microbiota compositionS Bibbò, G Ianiro, V Giorgio, et al.
European Review for Medical and Pharmacological Sciences|January 11, 2005
Platelets: new players in the mucosal scenario of inflammatory bowel diseaseS Danese, F Scaldaferri, A Papa, et al.
Drugs of Today (Barcelona, Spain : 1998)|April 12, 2018
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an updateG Holleran, F Scaldaferri, G Ianiro, et al.
European Review for Medical and Pharmacological Sciences|January 21, 2010
Small bowel bacterial overgrowth and type 1 diabetesV Ojetti, D Pitocco, E Scarpellini, et al.
Pageof 5